FindTrial
Sign In

Characterisation of the cytokine response in the Acute Coronary Syndrome and its modulation with angiotensin-converting enzyme inhibition (Protocol B)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN51684951
Enrollment
Unknown
Registered
2003-09-12
Start date
2002-10-31
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome Circulatory System Other acute ischaemic heart diseases

Interventions

Randomised controlled trial. Random allocation to: 1. Standard management 2. Standard management + angiotensin-converting enzyme inhibitor

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient population will be drawn from all patients admitted to the cardiac unit based at the Leeds General Infirmary or St James's University Hospital with chest pain within the preceding 24 h. Patients must have a history and electrocardiogram (ECG) changes consistent with a diagnosis of the Acute Coronary Syndrome.

Exclusion criteria

Exclusion criteria: Patients with ST elevation myocardial infarction

Design outcomes

Primary

MeasureTime frame
Cytokine levels measured in the blood peripheral venous blood—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026